ST Jiabiyou announced that due to the serious impact of the company's production and operation activities and not expected to return to normal within 3 months, other risk warnings will be implemented for stocks starting July 28, 2026. At present, the company's supply chain has been upgraded, products meet the latest testing requirements, some major health business customers have resumed stable supply, and new business expansion such as animal nutrition, beauty and personal care is progressing, and industrialization achievements related to synthetic biology continue to transform. The company will disclose the progress of the risk warning every month. If the annual revenue of 2026 falls below 100 million yuan, it may be subject to a delisting risk warning, and there is uncertainty about the time for performance recovery.

ST Jiabiyou announced that due to the serious impact of the company's production and operation activities and not expected to return to normal within 3 months, other risk warnings will be implemented for stocks starting July 28, 2026. At present, the company's supply chain has been upgraded, products meet the latest testing requirements, some major health business customers have resumed stable supply, and new business expansion such as animal nutrition, beauty and personal care is progressing, and industrialization achievements related to synthetic biology continue to transform. The company will disclose the progress of the risk warning every month. If the annual revenue of 2026 falls below 100 million yuan, it may be subject to a delisting risk warning, and there is uncertainty about the time for performance recovery.